Yu, Y., Villanueva-Meyer, J., Grimmer, M. R., Hilz, S., Solomon, D. A., Choi, S., Wahl, M., Mazor, T., Hong, C., Shai, A., Phillips, J. J., Wainer, B. H., McDermott, M., Haas-Kogan, D., Taylor, J. W., Butowski, N., Clarke, J. L., Berger, M. S., Molinaro, A. M., Chang, S. M., Costello, J. F., & Oberheim Bush, N. A. (2021). temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas. Neuro-oncology, 23(11), 1872–1884. http://access.bl.uk/ark:/81055/vdc_100146089652.0x000008